Gevo (GEVO) : Average target price received by Gevo (GEVO) is $2.5 with an expected standard deviation of $2.12. The most aggressive target on the stock is $4, whereas the most downbeat target is $1. 2 financial analysts are currently covering the stock.
Gevo (GEVO) : Zacks Investment Research ranks Gevo (GEVO) as 2, which is a Buy recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 2 research analysts is 2, which indicates as a Buy.
Gevo (NASDAQ:GEVO): The stock opened at $0.57 on Thursday but the bulls could not build on the opening and the stock topped out at $0.58 for the day. The stock traded down to $0.56 during the day, due to lack of any buying support eventually closed down at $0.57 with a loss of -4.20% for the day. The stock had closed at $0.59 on the previous day. The total traded volume was 1,713,745 shares.
Gevo, Inc. (Gevo) is a renewable chemicals and biofuels company. The Compnay is focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The Company operates through two segments: the Gevo, Inc. and the Gevo Development/Agri-Energy. The Gevo, Inc. segment is responsible for all research and development activities related to the production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. The Gevo Development/Agri-Energy Segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.